Michał Kaza

Deputy Head

Poland

Research Interests

Explore related searches

Professors in Poland

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Michał Kaza serves as the Deputy Head at Celon Pharma in Poland. His research focuses on bioequivalence and bioavailability studies, particularly in relation to pharmaceutical formulations such as Ticagrelor and Rivaroxaban. He has contributed significantly to the field through recent publications that explore innovative bioanalytical methods and the application of two-stage designs in bioequivalence testing.

Articles (5)

Year:

2025

Year:

2024

Year:

2021

Year:

2020

Year:

2020

Collaborators (2)

Piotr J. Rudzki

Head

POLAND

View details

Agnieszka Segiet-Swiecicka

National Institute of Cardiology

POLAND

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Michał Kaza

Research Interests

Explore related searches

Contact this professor

About

Articles (5)

Relative Bioavailability of Ticagrelor from Hard Capsules and Film-Coated Tablets in Healthy Caucasian Volunteers

Bioequivalence of Rivaroxaban Hard Capsules vs. Film-Coated Tablets in Healthy White Volunteers

LC-MS/MS determination of dutasteride and its major metabolites in human plasma

10th Anniversary of a Two-Stage Design in Bioequivalence. Why Has it Still Not Been Implemented?

Visualizing bioanalytical methods – a near or distant future?

Collaborators (2)

Piotr J. Rudzki

Agnieszka Segiet-Swiecicka

Make your next move.